Zobrazeno 1 - 10
of 47
pro vyhledávání: '"María, González Cao"'
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/a71637a762b04bf3be25a17680e25ef7
Autor:
Rafael Rosell, Anisha Jain, Jordi Codony-Servat, Eloisa Jantus-Lewintre, Blake Morrison, Jordi Barretina Ginesta, María González-Cao
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 7, Pp 500-518 (2023)
Lung oncogenesis relies on intracellular cysteine to overcome oxidative stress. Several tumor types, including non-small cell lung cancer (NSCLC), upregulate the system xc- cystine/glutamate antiporter (xCT) through overexpression of the cystine tran
Externí odkaz:
https://doaj.org/article/c75dc006ae7f4f98914e3994f585c6bd
Autor:
Valentina Casella, Paula Cebollada Rica, Jordi Argilaguet, Enric Vidal, María González-Cao, Roberto Güerri-Fernandez, Gennady Bocharov, Andreas Meyerhans
Publikováno v:
Viruses, Vol 16, Iss 5, p 799 (2024)
Immunotherapy with checkpoint inhibitors, albeit commonly used against tumors, is still at its infancy against chronic virus infections. It relies on the reinvigoration of exhausted T lymphocytes to eliminate virus-infected cells. Since T cell exhaus
Externí odkaz:
https://doaj.org/article/05b3bfd9423f4bad98694a638d985b6e
Autor:
Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, Rocío López-Vacas, Virtudes Soriano, Fernando Garicano, M. José Lecumberri, María Rodríguez de la Borbolla, Margarita Majem, Elisabeth Pérez-Ruiz, María González-Cao, Juana Oramas, Alejandra Magdaleno, Joaquín Fra, Alfonso Martín-Carnicero, Mónica Corral, Teresa Puértolas, Ricardo Ramos-Ruiz, Antje Dittmann, Paolo Nanni, Juan Ángel Fresno Vara, Enrique Espinosa
Publikováno v:
Cancers, Vol 15, Iss 17, p 4407 (2023)
Immunotherapy improves the survival of patients with advanced melanoma, 40% of whom become long-term responders. However, not all patients respond to immunotherapy. Further knowledge of the processes involved in the response and resistance to immunot
Externí odkaz:
https://doaj.org/article/6da6bdb748d84ad08bfecc4b64fa7420
Autor:
Rafael Rosell, María González-Cao
Publikováno v:
The Lancet Regional Health. Europe, Vol 22, Iss , Pp 100494- (2022)
Externí odkaz:
https://doaj.org/article/c6887458e9874bcc81ee19bdc8e0472c
Autor:
Niki Karachaliou, Jordi Codony-Servat, Cristina Teixidó, Sara Pilotto, Ana Drozdowskyj, Carles Codony-Servat, Ana Giménez-Capitán, Miguel Angel Molina-Vila, Jordi Bertrán-Alamillo, Radj Gervais, Bartomeu Massuti, Teresa Morán, Margarita Majem, Enriqueta Felip, Enric Carcereny, Rosario García-Campelo, Santiago Viteri, María González-Cao, Daniela Morales-Espinosa, Alberto Verlicchi, Elisabetta Crisetti, Imane Chaib, Mariacarmela Santarpia, José Luis Ramírez, Joaquim Bosch-Barrera, Andrés Felipe Cardona, Filippo de Marinis, Guillermo López-Vivanco, José Miguel Sánchez, Alain Vergnenegre, José Javier Sánchez Hernández, Isabella Sperduti, Emilio Bria, Rafael Rosell
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/907f95952a6f451dab4695071025b8b3
Autor:
Manuel Sánchez-Prieto, Francesc Fargas, Francesc Tresserra, María González-Cao, Sonia Baulies, Rafael Fábregas
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1144-1151 (2021)
Vulvar malignant melanoma is the second most common subtype of vulvar cancer, accounting for 5–10% of all vulvar cancers. The prognosis is still very poor, although some advances have been achieved in the last years. One of the most significant cha
Externí odkaz:
https://doaj.org/article/429026ae82684c78af9a8a59dfd15596
Autor:
Marta Sisteré-Oró, Naina Andrade, Diana D.J. Wortmann, Juan Du, Natalia Garcia-Giralt, María González-Cao, Robert Güerri-Fernández, Andreas Meyerhans
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Individuals infected with the human immunodeficiency virus type 1 (HIV-1) belong to the group of people most vulnerable to SARS-CoV-2 infections and the associated disease COVID-19. Here we describe SARS-CoV-2-specific antibody and cellular immune re
Externí odkaz:
https://doaj.org/article/e60ed32317554dfb80efcb1acf9208ff
Publikováno v:
Cancers, Vol 15, Iss 9, p 2519 (2023)
Genetic mutations can activate different sets of proto-oncogenes and tumor suppressors genes [...]
Externí odkaz:
https://doaj.org/article/2c971eb3d44a43e2b697968f1b9bcb4e
Autor:
Cristina Aguado, Cristina Teixido, Ruth Román, Roxana Reyes, Ana Giménez‐Capitán, Elba Marin, Carlos Cabrera, Nuria Viñolas, Sergi Castillo, Silvia Muñoz, Ainara Arcocha, Laura López‐Vilaró, Ivana Sullivan, Erika Aldeguer, Sonia Rodríguez, Irene Moya, Santiago Viteri, Andrés Felipe Cardona, Ramon Palmero, Cristina Sainz, Miguel Mesa‐Guzmán, Maria D. Lozano, Andrés Aguilar‐Hernández, Alejandro Martínez‐Bueno, María González‐Cao, Elena Gonzalvo, William P. J. Leenders, Rafael Rosell, Luis M. Montuenga, Aleix Prat, Miguel A. Molina‐Vila, Noemi Reguart
Publikováno v:
Molecular Oncology, Vol 15, Iss 2, Pp 350-363 (2021)
MET inhibitors have shown activity in non‐small‐cell lung cancer patients (NSCLC) with MET amplification and exon 14 skipping (METΔex14). However, patient stratification is imperfect, and thus, response rates have varied widely. Here, we studied
Externí odkaz:
https://doaj.org/article/5db041644f0248ee90bd178c373b1867